Adult lifetime cost of hemophilia B management in the US: Payer and societal perspectives from a decision analytic model.

CONCLUSIONS: This decision analytic model demonstrated significant economic burden associated with the current HB treatment paradigm. PMID: 33591884 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33591884?dopt=Abstract

Source: Journal of Medical Economics - February 18, 2021 Category: Health Management Tags: J Med Econ Source Type: research